Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know [Yahoo! Finance]
Ligand Pharmaceuticals Incorporated (LGND)
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ligand.com
Company Research
Source: Yahoo! Finance
Espinoza reported the sale of 3,057 shares of common stock for a transaction value of approximately $688,000, according to a SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value Post-transaction common shares (direct) Post-transaction value (direct ownership) ~$4.65 million Transaction value based on SEC Form 4 weighted average purchase price ($225.00); post-transaction value based on trade-date close price. Key questions How does the size of this sale compare to Espinoza's historical selling activity? The 3,057 shares sold in this transaction match the recent period median for Espinoza's sell transactions since December 2024. What is the context behind the transaction's derivative nature? The filing discloses that 2,405 underlying shares were acquired through the exercise of vested stock options, with the entire 3,057-share block sold immediately. What proportion of Espinoza's remaining equity exposure does this trans
Show less
Read more
Impact Snapshot
Event Time:
LGND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGND alerts
High impacting Ligand Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
LGND
News
- Ligand Advances Strategic Growth with Expanded and Strengthened Business Development TeamGlobeNewswire
- Ligand Pharmaceuticals (LGND) had its price target raised by Citigroup Inc. from $270.00 to $276.00. They now have a "buy" rating on the stock.MarketBeat
- Ligand Pharmaceuticals: Reliable Midcap Pharma With Perfected High Growth Business Model [Seeking Alpha]Seeking Alpha
- Ligand Pharmaceuticals offers high-margin exposure to biopharma growth, BofA says [Yahoo! Finance]Yahoo! Finance
- Ligand Pharmaceuticals (LGND) is now covered by Bank of America Corporation. They set a "buy" rating and a $244.00 price target on the stock.MarketBeat
LGND
Earnings
- 2/26/26 - Beat
LGND
Sec Filings
- 3/27/26 - Form 4
- 3/27/26 - Form 4
- 3/27/26 - Form 4
- LGND's page on the SEC website